Results 351 to 355 of about 496,062 (355)

Long‐term follow‐up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper‐CVAD), a dose‐intensive regimen, in adult acute lymphocytic leukemia

Cancer, 2004
Hagop M Kantarjian, Susan M O'brien, Francis J Giles   +2 more
exaly  

Effects of dexamethasone on early cognitive decline after cardiac surgery: A randomised controlled trial

European Journal of Anaesthesiology, 2017
Sandro Glumac, G. Kardum, Lidija Šodić, Daniela Šupe-Domić, N. Karanović   +4 more
semanticscholar   +1 more source

Electrochemically Controlled Drug Release from a Conducting Polymer Hydrogel (PDMAAp/PEDOT) for Local Therapy and Bioelectronics

Advanced Healthcare Materials, 2019
Carolin Kleber, Karen Lienkamp, Jürgen Rühe   +2 more
exaly  

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma

Leukemia, 2009
exaly  

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

British Journal of Haematology, 2004
exaly